-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QLt8BGkzXxXqGATbeCnrIsGbXGEnbW2bDn04Oih+J7jG3UD0SmIKqOBnRVdKV+eC tCctondE2KAhGMXWYrXdQQ== 0000906337-02-000028.txt : 20021031 0000906337-02-000028.hdr.sgml : 20021031 20021031124023 ACCESSION NUMBER: 0000906337-02-000028 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021029 FILED AS OF DATE: 20021031 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MCNAMARA KEVIN M CENTRAL INDEX KEY: 0001200996 RELATIONSHIP: DIRECTOR FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: C/O PROXYMED INC STREET 2: 2555 DAVIE ROAD STE 110 CITY: FORT LAUDERDALE STATE: FL ZIP: 33317 BUSINESS PHONE: 9544731001 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PROXYMED INC /FT LAUDERDALE/ CENTRAL INDEX KEY: 0000906337 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 650202059 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22052 FILM NUMBER: 02804531 BUSINESS ADDRESS: STREET 1: 2555 DAVIE ROAD STREET 2: SUITE 110 CITY: FORT LAUDERDALE STATE: FL ZIP: 33317-7424 BUSINESS PHONE: 9544731001 MAIL ADDRESS: STREET 1: 2555 DAVIE ROAD STREET 2: SUITE 110 CITY: FT LAUDERDALE STATE: FL ZIP: 33317 FORMER COMPANY: FORMER CONFORMED NAME: HMO PHARMACY INC DATE OF NAME CHANGE: 19930601 3 1 edgar.txt FORM 3 - 10/29/2002 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 1. Name and Address of Reporting Person McNamara, Kevin M c/o 2555 Davie Road, Suite 110 Fort Lauderdale, FL 33317 USA 2. Date of Event Requiring Statement (Month/Day/Year) 10/29/2002 3. IRS or Social Security Number of Reporting Person (Voluntary) 4. Issuer Name and Ticker or Trading Symbol ProxyMed, Inc. PILL 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) (X) Director ( ) 10% Owner ( ) Officer (give title below) ( ) Other (specify below) Director 6. If Amendment, Date of Original (Month/Day/Year) 7. Individual or Joint/Group Filing (Check Applicable Line) (X) Form filed by One Reporting Person ( ) Form filed by More than One Reporting Person
___________________________________________________________________________________________________________________________________ Table I -- Non-Derivative Securities Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1. Title of Security |2. Amount of |3. Ownership |4. Nature of Indirect | | Securities | Form: | Beneficial Ownership | | Beneficially | Direct(D) or | | | Owned | Indirect(I) | | ___________________________________________________________________________________________________________________________________| ___________________________________________________________________________________________________________________________________| ___________________________________________________________________________________________________________________________________ Table II -- Derivative Securitites Beneficially Owned | ___________________________________________________________________________________________________________________________________| 1.Title of Derivative |2.Date Exer- |3.Title and Amount | |4. Conver-|5. Owner- |6. Nature of Indirect | Security | cisable and | of Underlying | |sion or |ship | Beneficial Ownership | | Expiration | Securities | |exercise |Form of | | | Date(Month/ |-----------------------|---------|price of |Deriv- | | | Day/Year) | |Amount |deri- |ative | | | Date | Expira- | |or |vative |Security: | | | Exer- | tion | Title |Number of|Security |Direct(D) or | | | cisable | Date | |Shares | |Indirect(I) | | ___________________________________________________________________________________________________________________________________| Stock Options |10/29/03 |10/29/12 |Common Stock |5,000 |$12.54 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Stock Options |10/29/04 |10/29/12 |Common Stock |5,000 |$12.54 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Stock Options |10/29/05 |10/29/12 |Common Stock |5,000 |$12.54 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| Stock Options |10/29/05*|10/29/12 |Common Stock |1,875 |$12.54 |D | | - -----------------------------------------------------------------------------------------------------------------------------------| ___________________________________________________________________________________________________________________________________|
Explanation of Responses: *Vesting will occur in full after 3 years; however, 625 options may be "accelerated" to vest immediately after attendance at each meeting (based upon 4 Board of Directors' Committee meetings per year). SIGNATURE OF REPORTING PERSON Kevin M. McNamara DATE October 31, 2002 -----END PRIVACY-ENHANCED MESSAGE-----